Trial Profile
Evaluation of pneumococcal conjugate vaccine (Prevenar) [pneumococcal 7-valent CRM197 vaccine conjugate] in patients with myeloma and chronic lymphocytic leukaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2019
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 07 Nov 2006 New trial record.